这就是P.O.L.A.R.R.的意思. 星星:一家中型制药公司开发并应用的新框架,以推动研发领域的数字化转型
Riccardo Mariani1, Maria Carmela De Vuono2, Elena Businaro2
1Chiesi Farmaceutici Spa, Largo Francesco Belloli 11/A, 43122, Parma, Italy. r.mariani@chiesi.com.
Pharmaceutical medicine
|August 9, 2024
概括
奇伊西为制药研发 (R&D) 开发了一个数字化转型框架. 这一框架增强了创新,数据管理和协作,最终改善了患者护理.
科学领域:
- 制药研究和开发 制药研发
- 数字化转型 数字化转型
- 创新管理 创新管理
背景情况:
- 数字化转型对于制药研发创新至关重要,即使对于较小的公司来说也是如此.
- 由于资源有限,中小型制药企业在采用数字化战略方面面临挑战.
研究的目的:
- 描述Chiesi的框架,以推动整个研发价值链的数字化转型.
- 建立一个明确的路线图,确定优先事项,并在研发中发展数字能力和技能.
- 定义指导中长期数字研发活动的工具和流程.
主要方法:
- 制定战略路线图,包括重点领域和专门的团队.
- 在整个研发价值链中建立一个共同的数据语言.
- 培养创新的内部思维方式,并参与外部网络.
- 实施快速获胜的用例,并定义关键绩效指标 (KPIs) 和监测工具.
主要成果:
- 一个战略一致的研发数字化转型路线图和一个专注的领导团队.
- 标准化数据语言和准备好创新的内部文化.
- 成功实施快速获胜的数字使用案例和强大的KPI监控.
- 证明了推动跨职能协作和数据集成的能力.
结论:
- 研发数字化转型是一个持续的过程,对复杂的制药环境至关重要.
- 有效的转型能够有效地支持企业,并对患者护理产生积极影响.
- 奇伊西框架为整合数字能力和管理各种数据量提供了一个模型.
相关概念视频
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Structure-Activity Relationships and Drug Design
687
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
687
Drug Administration and Therapy Phases: Overview
425
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
425
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K


